Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program

Idilman, R.Demir, M.Aladag, M.Kaymakoglu, S.Erol, C.Cavus, B.Iliaz, R.2024-09-182024-09-1820180168-82781600-0641https://hdl.handle.net/20.500.12483/13065International Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCE[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessRecurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access programConference Object68S301S301WOS:000461068601213Q1